Antonino Maria Tommaso Buffon

Medicine & Life Sciences

1. Acute Coronary Syndrome 100%
2. Meta-Analysis 88%
3. Percutaneous Coronary Intervention 80%
4. ST Elevation Myocardial Infarction 73%
5. Drug-Eluting Stents 54%
6. Ticagrelor 49%
7. Myocardial Ischemia 40%
8. Myocardial Infarction 38%
9. Optical Coherence Tomography 34%
10. Randomized Controlled Trials 32%
11. Coronary Vessels 32%
12. Stable Angina 30%
13. Coronary Artery Disease 27%
14. Atherosclerotic Plaques 25%
15. Spasm 25%
16. Adenosine 24%
17. Blood Platelets 22%
18. Cardiomyopathies 22%
19. Atrial Fibrillation 20%
20. Polymers 20%
21. Mortality 19%
22. Myocardial Bridging 18%
23. Microvascular Angina 18%
24. Clopidogrel 17%
25. Stents 17%
26. Systematic Reviews 17%
27. Proprotein Convertase 9 16%
28. Cardiogenic Shock 16%
29. Prasugrel Hydrochloride 16%
30. Sodium Bicarbonate 16%
31. Acetylcysteine 16%
32. Clay 16%
33. Takotsubo Cardiomyopathy 15%
34. Unstable Angina 15%
35. Network Meta-Analysis 15%
36. Thioctic Acid 15%
37. Non-ST Elevated Myocardial Infarction 15%
38. Phenotype 14%
39. Null Lymphocytes 14%
40. Pioglitazone 14%
41. Safety 14%
42. Cardiology 14%
43. Transcatheter Aortic Valve Replacement 14%
44. Laryngeal Neoplasms 14%
45. Biopsy 14%
46. Implantable Defibrillators 13%
47. Low Molecular Weight Heparin 13%
48. Saphenous Vein 12%
49. Registries 12%
50. Therapeutics 12%